| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Landos Biopharma, Inc. | Director | Stock Option (right to buy) | 0 | 23 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000141588924014336-garabedian-christopher-nishan-2024-05-23 | Landos Biopharma, Inc. | 23 May 2024 | 3 | $0 | 4 | Director | 23 May 2024, 17:45 |
| /report/000120919123031943-garabedian-christopher-nishan-2023-05-23 | Landos Biopharma, Inc. | 23 May 2023 | 1 | $0 | 4 | Director | 24 May 2023, 17:53 |
| /report/000120919122035285-garabedian-christopher-nishan-2022-06-07 | Landos Biopharma, Inc. | 07 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 08:53 |
| /report/000120919122030044-garabedian-christopher-nishan-2022-05-16 | Landos Biopharma, Inc. | 16 May 2022 | 1 | $0 | 4 | Director | 18 May 2022, 16:28 |